PMID- 34491392
OWN - NLM
STAT- MEDLINE
DCOM- 20220406
LR  - 20221207
IS  - 1615-2573 (Electronic)
IS  - 0910-8327 (Linking)
VI  - 37
IP  - 3
DP  - 2022 Mar
TI  - Validation of the correlation between angiosome-based target arterial path, 
      mid-term limb-based patency, and the global limb anatomical staging system.
PG  - 496-504
LID - 10.1007/s00380-021-01937-5 [doi]
AB  - This study aimed to validate the correlation between the Global Limb Anatomical 
      Staging System (GLASS) and limb-based patency (LBP) and angiosome-based target 
      arterial path (TAP) and to detect the predictors of LBP loss. After the 
      publication of the Global Vascular Guidelines in 2019, the evaluation of GLASS 
      and identification of TAP have been recommended. However, there are few reports 
      regarding GLASS. Eighty-three patients with chronic limb-threatening ischemia 
      (CLTI) and tissue loss from 2016 to 2020 were evaluated. The correlation between 
      GLASS and LBP and successful revascularization of angiosome-based TAP was 
      analyzed. We also investigated the predictors of LBP loss. The number of patients 
      in each GLASS stage was as follows: GLASS I, 6 patients; GLASS II, 15 patients; 
      GLASS III, 62 patients. At 6 months, the Kaplan-Meier estimate of LBP was 66.7% 
      in GLASS I, 41.6% in GLASS II, and 16.4% in GLASS III, respectively (p = 0.034). 
      The rate of successful revascularization of angiosome-based TAP was 100% in GLASS 
      I, 86.7% in GLASS II, and 46.8% in GLASS III, respectively (p = 0.002). 
      Multivariate analysis showed that the Wound, Ischemia, and foot Infection (WIfI) 
      stage [hazard ratio (HR) 1.58; 95% confidence interval (CI) 1.07-2.33; p = 0.021] 
      and GLASS infrapopliteal (IP) grade (HR 1.96; 95% CI 1.31-2.95; p = 0.001) were 
      the independent predictors of LBP loss. The GLASS stage was significantly 
      correlated with successful revascularization of angiosome-based TAP and mid-term 
      LBP. The WIfI stage and GLASS IP grade were the independent predictors of loss of 
      LBP.
CI  - (c) 2021. Springer Japan KK, part of Springer Nature.
FAU - Yamada, Takehiro
AU  - Yamada T
AUID- ORCID: 0000-0001-9711-1054
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan. t.yamada1104@gmail.com.
FAU - Shibahara, Taro
AU  - Shibahara T
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
FAU - Nagase, Masaru
AU  - Nagase M
FAU - Ono, Daiju
AU  - Ono D
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
FAU - Tanabe, Gen
AU  - Tanabe G
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
FAU - Suzuki, Keita
AU  - Suzuki K
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
FAU - Yamaura, Makoto
AU  - Yamaura M
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
AD  - Division of Molecular Pathology, Shinshu University of Medicine, Matsumoto, 
      Japan.
FAU - Ido, Takahisa
AU  - Ido T
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
AD  - Division of Cardiology, Gifu University of Medicine, Gifu, Japan.
FAU - Nakashima, Takashi
AU  - Nakashima T
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
AD  - Division of Cardiology, Gifu University of Medicine, Gifu, Japan.
FAU - Takahashi, Shigekiyo
AU  - Takahashi S
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
AD  - Division of Cardiology, Gifu University of Medicine, Gifu, Japan.
FAU - Aoyama, Takuma
AU  - Aoyama T
AD  - Division of Cardiology, Cardiovascular Center, Kizawa Memorial Hospital, 590 
      Shimokobi, Kobi, Gifu, Minokamo, 5058503, Japan.
AD  - Division of Molecular Pathology, Shinshu University of Medicine, Matsumoto, 
      Japan.
AD  - Division of Cardiology, Gifu University of Medicine, Gifu, Japan.
LA  - eng
PT  - Journal Article
DEP - 20210907
PL  - Japan
TA  - Heart Vessels
JT  - Heart and vessels
JID - 8511258
SB  - IM
MH  - Amputation, Surgical
MH  - Chronic Disease
MH  - *Endovascular Procedures
MH  - Humans
MH  - Ischemia
MH  - Limb Salvage
MH  - *Peripheral Arterial Disease
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Chronic limb-threatening ischemia
OT  - Endovascular therapy
OT  - Global limb anatomical staging system
OT  - Peripheral artery disease
OT  - Target arterial path
EDAT- 2021/09/08 06:00
MHDA- 2022/04/07 06:00
CRDT- 2021/09/07 12:33
PHST- 2021/05/20 00:00 [received]
PHST- 2021/09/03 00:00 [accepted]
PHST- 2021/09/08 06:00 [pubmed]
PHST- 2022/04/07 06:00 [medline]
PHST- 2021/09/07 12:33 [entrez]
AID - 10.1007/s00380-021-01937-5 [pii]
AID - 10.1007/s00380-021-01937-5 [doi]
PST - ppublish
SO  - Heart Vessels. 2022 Mar;37(3):496-504. doi: 10.1007/s00380-021-01937-5. Epub 2021 
      Sep 7.